A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
Public ClinicalTrials.gov record NCT00048035. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Multicenter, Randomized Study to Determine Dose Conversion Factors at Different Frequencies of Administration After Switching From Maintenance Treatment With Intravenous Epoetin Alfa to Maintenance Treatment With Intravenous RO0503821 in Hemodialysis Patients With Chronic Renal Anemia.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will determine the appropriate dose and frequency of administration of iv Mircera maintenance therapy in hemodialysis patients with chronic renal anemia who were previously receiving iv epoetin. The anticipated time on study treatment is 3-12 months and the target sample size is \<100 individuals.
Study identification
- NCT ID
- NCT00048035
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 91 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2002
- Primary completion
- May 31, 2005
- Completion
- May 31, 2005
- Last update posted
- Dec 19, 2016
2002 – 2005
United States locations
- U.S. sites
- 14
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35211 | — |
| Not listed | Los Angeles | California | 90095 | — |
| Not listed | Maywood | Illinois | 60153 | — |
| Not listed | Louisville | Kentucky | 40202-1718 | — |
| Not listed | Detroit | Michigan | 48202-2689 | — |
| Not listed | Detroit | Michigan | 48236 | — |
| Not listed | Brooklyn Center | Minnesota | 55430 | — |
| Not listed | Las Vegas | Nevada | 89106 | — |
| Not listed | Paterson | New Jersey | 07503 | — |
| Not listed | Brooklyn | New York | 11203 | — |
| Not listed | Mineola | New York | 11501 | — |
| Not listed | New York | New York | 10128 | — |
| Not listed | Nashville | Tennessee | 37232 | — |
| Not listed | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Anemia trials
Other public records listing Anemia. Sorted by last update posted; newest first. Not a recommendation.
- NCT07725497: A Study of Luspatercept in People With Anemia Recruiting
- NCT07623161: A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib Recruiting
- NCT07422480: A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions Recruiting
- NCT07671469: Personalized Blood Transfusion Protocol for Cardiac Patients Not yet recruiting
- NCT06042699: Kids With Iron Deficiency and Scoliosis Recruiting
- NCT05800600: Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00048035, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 19, 2016 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00048035 live on ClinicalTrials.gov.